Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 23, 2010

Premium

Stephen Lombardi has left his job as president of Helicos BioSciences, and current CEO Ronald Lowy will take over the position, the company said in a recent filing with the US Securities and Exchange Commission.

Lombardi, who also has resigned from the firm's board of directors, will receive the amount of his gross annual salary of $375,000 in severance, plus stock options. Prior to joining Helicos, Lombardi had served as senior vice president at Affymetrix. Lowy has been CEO of Helicos since late 2007, and before that he was CEO and president of Fisher Biosciences, part of Thermo Fisher Scientific.


The Human Genome Organization has re-elected its president Edison Liu. Liu is executive director of the Genome Institute of Singapore and he has been HUGO's president since 2007.


Martin Schneider is now chair of the advisory board of imaGenes, the Berlin-based genomics services company said last week. Schneider replaces Klaus Schmidt-Menschner, who left to pursue other interests. Schneider is head of global therapeutic research at Bayer Schering Pharma. He was previously head of global target discovery and biomarkers at Bayer. Before that, he was head of enabling technologies at Schering.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.